Animalcare has announced the launch of a new epilepsy monitoring programme to support users of its Phenoleptil (phenobarbital) tablets.

As part of the programme, veterinary surgeons can have patients' phenobarbital plasma levels analysed by Carmichael Torrance Diagnostic Service (CTDS). CTDS Veterinary Director Nick Carmichael (RCVS Recognised Specialist in Veterinary Clinical Pathology) and his team will also be available both to interpret results and discuss all aspects of therapeutic monitoring at no extra cost.

In addition, veterinary surgeons can opt for additional chemistry, including bile acids to assess hepatic function plus haematology. All Phenoleptil users are eligible for 50% discount off these services.

Animalcare has also expanded the Phenoleptil range and launched new strength tablets of 25mg and 100mg. Presented as new "snap- tabs" with a four-way score for more accurate dosing, whatever the weight of the dog, this enables fine adjustments to be made thereafter, reducing the risk of sub-optimal dosing. 

The 100 tablet packs are designed for quick and easy dispensing with flavoured tablets to aid compliance. The 12.5mg and 25mg strengths are the only phenobarbital tablets licensed for dogs under 12kg and make it possible to treat dogs as low as 2.5kg (assuming a 2.5mg/kg bid starting dose) in weight. The 100mg tablets are useful to treat larger dogs.

For more information, contact your local Animalcare representative.

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.